KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Free Cash Flow (2016 - 2025)

Astrana Health's Free Cash Flow history spans 16 years, with the latest figure at $7.4 million for Q3 2025.

  • For Q3 2025, Free Cash Flow fell 76.63% year-over-year to $7.4 million; the TTM value through Sep 2025 reached $97.0 million, up 38.74%, while the annual FY2024 figure was $44.2 million, 11.26% up from the prior year.
  • Free Cash Flow for Q3 2025 was $7.4 million at Astrana Health, down from $89.5 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $89.5 million in Q2 2025 and bottomed at -$17.0 million in Q3 2022.
  • The 5-year median for Free Cash Flow is $11.3 million (2023), against an average of $16.0 million.
  • The largest annual shift saw Free Cash Flow crashed 366.78% in 2021 before it skyrocketed 513.52% in 2022.
  • A 5-year view of Free Cash Flow shows it stood at -$15.0 million in 2021, then surged by 513.52% to $62.0 million in 2022, then plummeted by 80.25% to $12.2 million in 2023, then plummeted by 210.1% to -$13.5 million in 2024, then surged by 154.93% to $7.4 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Free Cash Flow are $7.4 million (Q3 2025), $89.5 million (Q2 2025), and $13.6 million (Q1 2025).